Susanna Naggie, MD, is the Vice Dean for Clinical Research, Director of the Duke Clinical and Translational Science Institute (CTSI), and Associate Professor of Medicine in the Duke University School of Medicine. Dr. Naggie has direct responsibility for advancing the clinical research mission of the School of Medicine. She works closely with School of Medicine, Health System and Campus leaders including the Vice Dean for Translational Sciences, Vice Dean for Data Science and Information Technology, Executive Vice Dean for Administration, and Vice Dean and Executive Director of the Duke Clinical Research Institute (DCRI). She oversees the Duke Office of Clinical Research (DOCR) and Office of Regulatory Affairs & Quality. She also has a leadership role with the Clinical Research Units (CRUs), working closely with department CRU leadership.
Dr. Naggie is a physician-scientist focused on the care of patients with HIV and viral hepatitis and leads a research program aimed at understanding the mechanisms of accelerated liver fibrogenesis in this patient population and the development of biomarkers to guide medical decision making. She currently serves as chair of the AIDS Clinical Trials Group Viral Hepatitis Transformative Science Group Committee and was recently appointed to the NIH COVID-19 Treatment Guidelines Panel. Dr. Naggie earned her MD from Johns Hopkins School of Medicine and completed her Internal Medicine training at Duke University, where she also served as a Chief Resident in Internal Medicine. She completed her Infectious Diseases fellowship training at Duke, joining the faculty in the Division of Infectious Diseases in 2009.